EXELIXIS, INC.·4

Jun 3, 6:51 PM ET

Eckhardt Sue Gail 4

4 · EXELIXIS, INC. · Filed Jun 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Exelixis (EXEL) Director Eckhardt Sue Gail Sells 9,812 Shares

What Happened

  • Director Eckhardt Sue Gail sold 9,812 shares of Exelixis, Inc. (EXEL) on June 1, 2026. The sales were open-market transactions with a weighted-average price of $50.14, generating total proceeds of $491,974. Prices on individual trades ranged from $49.73 to $50.61.

Key Details

  • Transaction date: 2026-06-01; Sale (S) — open market/private sale.
  • Price details: weighted average $50.14; per-trade range $49.73–$50.61.
  • Proceeds: $491,974 (total).
  • 10b5-1 plan: Sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025 (see footnote).
  • Shares owned after transaction: the filing does not state a post-sale total; it notes the reporting person has 16,079 restricted stock units (RSUs) that will convert to common shares upon vesting.
  • Filing timeliness: Form 4 was filed on 2026-06-03 for a 2026-06-01 transaction — filed within the standard two-business-day window (timely).

Context

  • The sale was executed under a prearranged 10b5-1 plan, which typically schedules trades in advance and is considered routine; this does not necessarily indicate a change in the director’s view of the company. The filing notes unvested RSUs (16,079) that will become shares upon vesting.

Insider Transaction Report

Form 4
Period: 2026-06-01
Transactions
  • Sale

    Common Stock

    [F1][F2][F3]
    2026-06-01$50.14/sh9,812$491,97416,079 total
Footnotes (3)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025.
  • [F2]Represents the weighted average sales price. The shares of Exelixis, Inc. common Stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.73 to $50.61. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  • [F3]Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Signature
/s/ Nina Ayer, Attorney in Fact|2026-06-03

Documents

1 file
  • 4
    wk-form4_1780527116.xmlPrimary

    FORM 4